REUS NR

Manufacturer
REUS POLSKA SP Z O O
Effective date
2023-08-29
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:56:10

Label at a glance#

ProductREUS NR
Active ingredientNICOTINAMIDE MONONUCLEOTIDE
Label structure11 sections

Boxed warning

Warnings: Do not use: 1. as a substitute for sleep. This product is intended for occasional use only. 2. in children under 12 years of age. 3. If pregnant or breastfeeding, consult a healthcare professional before use. 4. Keep out of reach of children. In case of overdose, seek immediate medical attention or contact a poison control center. 5. Stop use and ask a doctor if fatigue or drowsiness persists or continue...

Storage and handling

Store in a dry place at 15oC - 30oC (59oF - 86oF)

Label contents#

Full prescribing information#

INACTIVE INGREDIENT SECTION

Silicon dioxide

Instructions on box

WARNINGS SECTION

Do not Use

as a substitute for sleep. This product is intended for accosional use only

in children under 12 years of age

BOXED WARNING SECTION

Warnings:

Do not use:

1. as a substitute for sleep. This product is intended for occasional use only.

2. in children under 12 years of age.

3. If pregnant or breastfeeding, consult a healthcare professional before use.

4. Keep out of reach of children. In case of overdose, seek immediate medical attention or contact a poison control center.

5. Stop use and ask a doctor if fatigue or drowsiness persists or continues to recur.

OTC - ACTIVE INGREDIENT SECTION

β-Nicotinamide Mononucleotide 600mg

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison control center right away.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast feeding, ask a health professional before use.

INDICATIONS & USAGE SECTION

Helps restore mental alertness or wafulness when experiencing fatigue or drowsiness

Adults and Children 12 years of age and over: take 2 capsules not more often than every 3 to 4 hours.

OTC - PURPOSE SECTION

Alertness aid

DOSAGE & ADMINISTRATION SECTION

each capsule contains Quercetin Phytosome 250mg, Trans-Resveratrol 150 mg

STORAGE AND HANDLING SECTION

Store in a dry place at 15oC - 30oC (59oF - 86oF)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BOXED WARNING SECTIONBOXED WARNING SECTION

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
83663-002-022024-07-30C16284748780-11030e365-24cb-111a-e063-dadaa90a10e2040bfcf7-f511-2fa1-e063-6394a90a5ef9
83663-002-022024-01-30C16284748780-11030e365-24cb-111a-e063-dadaa90a10e2040bfcf7-f511-2fa1-e063-6394a90a5ef9

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83663-002-01REUS NR80 in 1 BOTTLECAPSULE801
83663-002-02REUS NR80 in 1 BOTTLECAPSULE801

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
83663-002REUS NR CAPSULE [REUS POLSKA SP Z O O]12 package rows20230915_040bfcf7-f511-2fa1-e063-6394a90a5ef9.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83663-00283663-002-01, 83663-002-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
RESVERATROLQ369O8926LIACT
NICOTINAMIDE MONONUCLEOTIDE2KG6QX4W0VACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
040bfcf7-f512-2fa1-e063-6394a90a5ef9040bfcf7-f511-2fa1-e063-6394a90a5ef92023-08-29Boxed warning, WarningsExact identifier
spl id: 040bfcf7-f512-2fa1-e063-6394a90a5ef9
spl set id: 040bfcf7-f511-2fa1-e063-6394a90a5ef9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.